Rasmus Iversen

Immunologist and B-cell enthusiast at Oslo University Hospital.

[Rasmus Iversen @RasmusIv]

Very happy to share our latest preprint, where we address the relationship between systemic and gut IgA. See link below and details in 🧵. Huge thanks to everyone involved!

https://t.co/phzAHdAgpS

[Mayo Florida AutoImmune Neurology Group @Mayo_AING]

My lab is looking for an antibody engineer-protein biochemist to study ~500 patient derived monoclonal antibodies. Towards novel insights into autoAb-mediated neurological diseases #encephalitis #nmo #protein #antibody

Come n work at wonderful @MayoClinic Florida🏖️

Pls email me

[Rasmus Iversen @RasmusIv]

Collectively, our results suggest that systemic and gut IgA responses against bacteria originate from discrete anatomical sites with inductive sites in the upper aerodigestive tract likely playing a prominent role in generation of systemic IgA.

[Rasmus Iversen @RasmusIv]

Very happy to share our latest preprint, where we address the relationship between systemic and gut IgA. See link below and details in 🧵. Huge thanks to everyone involved!

https://t.co/phzAHdAgpS

[Rasmus Iversen @RasmusIv]

Notably, while IgA plasma cells in the bone marrow were almost exclusively of the IgA1 subclass, gut plasma cells showed an equal distribution between IgA1 and IgA2.

[Rasmus Iversen @RasmusIv]

I am looking for a PhD candidate to join my lab in Oslo! We are trying to understand the role of antigen-specific B cells in autoimmunity. See details and apply here 👇
https://t.co/vbBfbCU0dS

[Rasmus Iversen @RasmusIv]

Very excited to share our paper on enzyme-activating BCRs and their role in gluten-sensitive autoimmunity!
https://t.co/FUbLOiUsgg

https://t.co/EkSQMGd7To

[GreiffLab 💻🔬💊 @victorgreiff]

We have an open 2-year postdoc position focusing on computational approaches to identify antigen-specific immune receptors from adaptive immune repertoire data. Application deadline: Nov 6. https://t.co/cyIvlclfeU

[Vincent van Unen @VincentvUnen]

So excited! Hot off the press in @Nature
We present a human autoimmune organoid model capable of mimicking celiac disease. | driven by Antonio Santos! | Calvin Kuo Lab @StanfordMed

https://t.co/0ZwL9WiNjL

[GreiffLab 💻🔬💊 @victorgreiff]

Our paper on the linguistics-based formalization of antibody language is out in @NatComputSci. Work led by @MaiSpaceHa Rahmad Akbar and @PRobertImmodels . Summary thread: https://t.co/5QGruT3T2o.

[Rasmus Iversen @RasmusIv]

@LabPhan Thanks!

[Rasmus Iversen @RasmusIv]

Happy to share this story on autoreactive naive B cells of relevance to celiac disease. Out now in the Journal of Autoimmunity. More details in 🧵 https://t.co/zHReE2xJ1m

[Rasmus Iversen @RasmusIv]

Collectively, our study highlights the role of efficient T cell-B cell collaboration in development of celiac disease and production of disease-specific autoantibodies.

[Rasmus Iversen @RasmusIv]

The selected B cells are the ones that can interact productively with gluten-specific T cells. This requires that the B cells bind active TG2, which can form complexes with gluten. Hence, only some epitopes are permissive, and these end up dominating the autoantibody response.

[Rasmus Iversen @RasmusIv]

Our paper on circulating autoreactive B cells in celiac disease is now out in @CellReports 🎉. Big thanks to everyone involved!
https://t.co/hgAudTbiQU

[Rasmus Iversen @RasmusIv]

Very happy to share this story on autoreactive B cells in celiac disease together with @IdaLindeman @LeneHoydahl @ChristophAsb @LouiseFRisnes @JCoDiRC. Here, we identify a population of circulating IgA-switched B cells specific to the self-antigen transglutaminase 2 (TG2).

[Raquel Bartolomé-Casado @RBartolom]

I am so happy to share that our study has been published today in @Nature ! 🎉This has been an absolutely fantastic teamwork between @emilyethornton, @haemyisu @powrie_lab and @teichlab [Link: https://t.co/hMFDLxaTeR]

[GreiffLab 💻🔬💊 @victorgreiff]

New opening for a PhD student in my lab, co-supervised with @F_Lund_Johansen . This position is ERC-funded and focuses on novel experimental technologies for antibody-antigen binding screening 📷 https://t.co/T1KmMtxCPS